Arkolith/Insider Trading/CTTH/Form 4

CTT Pharmaceutical Holdings, Inc.

CEOCTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) · full profile →Form 4 · filed Sep 13, 2024
Net Buying
Open-Market Buys
$45
Open-Market Sells
$0
Net Open-Market Flow
$45
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2024Buy(P)750$0.06$455.0M
Sep 11, 2024Grant(A)750K$0.04$30K5.8M

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001035422-24-000025) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML